Article

Sponsored Content

N-1 Bioreactor Perfusion Capability

Author(s):

Samsung Biologics

• How alternating tangential filtration differs from other perfusion methods • The benefits of alternating tangential filtration

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Content
Site Logo
August 8th 2025

Vial Adapter Considerations for Cell and Gene Therapy Applications

West Pharmaceutical Services
Site Logo
August 8th 2025

The Roadmap to Asset Performance Management in Life Science

BlueMountain
Site Logo
August 8th 2025

Unlock the Future of Enterprise Asset Management with Agentic AI

BlueMountain
Site Logo
August 8th 2025

From Maintenance to Compliance: A Guide to CMMS/EAM Readiness

BlueMountain
Site Logo
August 8th 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

Lonza
Site Logo
August 8th 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

Catalent